Physician

Sheharyar S Khokhar, MD

According to 2025 Medicare claims, Sheharyar Khokhar, MD (NPI: 1093897761) practices nephrology in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is WESTERN NEW YORK MEDICAL PRACTICE P.C. (NPI: 1063790608; TIN: 61-1654232) and primary practice location at 14626-4122. Khokhar is affiliated with the Rochester Regional Health ACO, Inc. (ACO ID: A3476), participating under the MSSP model.

Khokhar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 300 traditional Medicare patients, billed 1,637 HCPCS/CPT codes, and received $243,107 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,068 prescription claims across 414 beneficiaries totaling $179,603 in drug costs, led by Clinolipid (Fat Emulsion/Olive/Soy/Phospho). DME data shows 57 claims. Open Payments data shows 9 records totaling $2,551. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $138,850 to $243,107. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $303,572 to $179,603. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	250	993	$138,850
2016	284	1,045	$143,321
2017	287	1,184	$152,543
2018	330	1,428	$159,452
2019	370	1,432	$184,247
2020	331	1,174	$173,465
2021	305	1,120	$191,966
2022	270	1,021	$187,412
2023	301	1,256	$204,444
2024	300	1,637	$243,107

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	242	1,740	$303,572
2016	248	1,851	$371,246
2017	243	1,762	$370,538
2018	259	1,931	$195,238
2019	262	1,998	$224,116
2020	260	1,764	$157,190
2021	303	1,721	$162,118
2022	336	1,975	$149,477
2023	349	1,841	$110,774
2024	414	2,068	$179,603

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	57	$1,575

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	93	517	$276
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	60	188	$230
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	56	68	$92
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	37	71	$62
90935	Hemodialysis procedure with physician evaluation	77	151	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clinolipid	Fat Emulsion/Olive/Soy/Phospho	43	301	$17,507
Farxiga	Dapagliflozin Propanediol	18	900	$17,109
Jardiance	Empagliflozin	16	660	$12,614
Prosol	Parenteral Amino Acid 20% No.1	103	724	$12,492
Sevelamer Carbonate	Sevelamer Carbonate	64	3,218	$11,145

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	13	$889
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	22	$396
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	11	$178
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	11	$113

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$2,551	Miach Orthopaedics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sheharyar S. Khokhar, MD?

Tedicare shows public-source Medicare data for Sheharyar S. Khokhar, MD (NPI 1093897761), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sheharyar S. Khokhar, MD have ACO affiliation data?

Sheharyar S. Khokhar, MD is shown with ACO affiliation data for Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476).

What billing organization is linked to Sheharyar S. Khokhar, MD?

Sheharyar S. Khokhar, MD is linked to WESTERN NEW YORK MEDICAL PRACTICE P.C. (billing NPI 1063790608) in the available physician profile data.

Does Sheharyar S. Khokhar, MD have Open Payments data?

Sheharyar S. Khokhar, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.